Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published August 1995 | public
Journal Article

FORSE-1, an Antibody That Labels Regionally Restricted Subpopulations of Progenitor Cells in the Embryonic Central Nervous System, Recognizes the Le^x Carbohydrate on a Proteoglycan and Two Glycolipid Antigens

Abstract

A key problem in nervous system development is how distinct subpopulations of progenitor cells give rise to different adult brain structures. The labeling pattern of the FORSE-1 antibody subdivides the neuroepithelium of the embryonic forebrain into domains resembling those of certain transcription factors, suggesting that the FORSE-1 epitope may be involved in the specification of developmental compartments. Therefore, it is important to determine the identity of the antigen(s) recognized by FORSE-1. On immunoblots, FORSE-1 recognizes a single, high-molecular-weight species, which we have identified as phosphacan, a brain-specific chondroitin sulfate proteoglycan that binds neural cell adhesion molecules. This identification is based on cross-immunoprecipitations and immunoblotting using an anti-phosphacan antibody and FORSE-1. FORSE-1 also recognizes two major neutral glycolipids in embryonic brain. The FORSE-1 epitope is sensitive to endo-β-galactosidase, suggesting that the epitope corresponds to a carbohydrate moiety. Moreover, immunoprecipitates of the proteoglycan bearing the FORSE-1 epitope bind antibodies that recognize the Lex carbohydrate, and immunostaining patterns of embryonic brain sections by FORSE-1 and a known anti-Le^x antibody are identical. Finally, purified FORSE-1 specifically recognizes Le^x-containing glycoconjugates in ELISAs. The pattern of FORSE-1 labeling, the identification of its epitope as Le^x, which has been implicated in cell adhesion, and the presence of Le^x on phosphacan suggest that this carbohydrate epitope may play a role in adhesive interactions important for proliferation, cell migration, or axon guidance.

Additional Information

© 1995 Academic Press. Received for publication June 20, 1995. Available online 2 May 2002. We thank Dr. Renee K. Margolis for the immunoblots of purified phosphacan and neurocan and for use of the anti-phosphacan antiserum. We thank Dr. Tom Jessell, Dr. Jane Dodd, and Dr. Michael Hadjiargyrou for insightful comments and discussions. We also thank Drs. Jessell and Dodd for the AC4, SSEA-1, and DA3 antibodies, and Dr. S. Hakomori for the FH6 antibody. We thank Michaela Wolf for technical assistance with ELISAs and TLC, Susan Ou for ascites production, Doreen McDowell for culture media, and Ors. Lisa Banner, Shilpi Banerjee, Rob Cabelli, Arlene Chiu, Zaven Kaprielian, Nagesh Mahanthappa, and Shubha Tole for critical reading of the manuscript. This work was supported by a grant from the NINDS to P.H.P. and an NRSA fellowship to K.L.A.

Additional details

Created:
August 20, 2023
Modified:
October 18, 2023